387 followers
RT @FrontImmunol: New Research: Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy: The…
RT @FrontImmunol: New Research: Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy: The…
New Research: Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy: The blockade of immunological negative regulators offered a novel therapeutic approach that revolutionized the immunotherapy… https://t.co